08048035996

RYBELSUS 3 MG contains semaglutide, an oral glucagon-like peptide-1 (GLP-1) receptor agonist used as part of treatment for adults with type 2 diabetes mellitus. It works by enhancing glucose-dependent insulin secretion, reducing glucagon release, and slowing gastric emptying, thereby helping improve blood glucose control. RYBELSUS 3 MG is the recommended starting strength and, according to current prescribing information, is generally taken once daily for the initial treatment period before the dose is adjusted by the prescribing healthcare professional. It should be taken on an empty stomach in the morning with a small amount of plain water, and patients should wait at least 30 minutes before eating, drinking other beverages, or taking other oral medicines. The tablet should be swallowed whole and should not be split, crushed, or chewed. Common adverse effects include nausea, abdominal pain, diarrhea, decreased appetite, vomiting, and constipation. RYBELSUS carries important precautions, including a contraindication in people with a personal or family history of medullary thyroid carcinoma or MEN 2. It should be used under medical supervision, particularly in patients with pancreatic, kidney, gallbladder, or diabetic eye conditions. For pharmaceutical product availability and export inquiries, contact Phoenix Exim, an Indian pharmaceutical exporter.

CONTACT PHOENIX EXIM

Contact No. / WhatsApp: +91-9307610860 & +91-9860818372
Email: phoenixexim2000@gmail.com 

Sep 25th, 2026 3:10 PM